Prevalence of obesity/adiposity in Japanese psoriasis patients: Adiposity is correlated with the severity of psoriasis (vol 54, pg 61, 2009)

被引：29

作者：

Takahashi, Hidetoshi ^{[1
]}

Tsuji, Hitomi ^{[1
]}

Takahashi, Ichiro ^{[1
]}

Hashimoto, Yoshio ^{[1
]}

Ishida-Yamamoto, Akemi ^{[1
]}

Iizuka, Hajime ^{[1
]}

机构：

[1] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan

来源：

JOURNAL OF DERMATOLOGICAL SCIENCE | 2009年 / 55卷 / 01期

关键词：

Body mass index; Disease activity; Percent body fat; Psoriasis; Visceral adiposity; METABOLIC SYNDROME; ADIPONECTIN; PROTEIN;

D O I：

10.1016/j.jdermsci.2009.04.003

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：74 / 76

页数：3

共 11 条

[1] Prevalence of obesity/adiposity in Japanese psoriasis patients: Adiposity is correlated with the severity of psoriasis
Takahashi, Hidetoshi
Tsuji, Hitomi
Takahashi, Ichiro
Hashimoto, Yoshio
Ishida-Yamamoto, Akemi
Iizuka, Hajime
[J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 54 (01) : 61 - 63
[2] The prevalence of onychomycosis in patients with psoriasis and other skin diseases (vol 83, pg 206, 2003)
Kiellberg, LG
Haedersdal, M
Svejgaard, EL
[J]. ACTA DERMATO-VENEREOLOGICA, 2003, 83 (06) : 470 - 470
[3] Visceral and Subcutaneous Adiposity and Adiponectin in Middle-aged Japanese Men: The ERA JUMP Study (vol 17, pg 1269, 2009)
Nakamura, Yasuyuki
Sekikawa, Akira
Kadowaki, Takashi
Kadota, Aya
Kadowaki, Sayaka
Maegawa, Hiroshi
Kita, Yoshikuni
Evans, Rhobert W.
Edmundowicz, Daniel
Curb, J. David
Ueshima, Hirotsugu
[J]. OBESITY, 2012, 20 (11) : 2320 - 2320
[4] Corneodesmosin DNA polymorphisms in MHC haplotypes and Japanese patients with psoriasis (vol 60, pg 77, 2002)
Hui, J
Oka, A
Tamiya, G
Tomizawa, M
Kulski, JK
Penhale, WJ
Tay, GK
Iizuka, M
Ozawa, A
Inoko, H
[J]. TISSUE ANTIGENS, 2003, 61 (02): : 184 - 187
[5] Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis (vol 139, pg 353, 2003)
Sampogna
[J]. ARCHIVES OF DERMATOLOGY, 2003, 139 (07) : 950 - 950
[6] Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity (vol 14, pg 1615, 2024)
Armstrong, April W.
Jaleel, Tarannum
Merola, Joseph F.
Gottlieb, Alice B.
Khattri, Saakshi
Helt, Cameron C.
Malatestinic, William N.
Ross, Sarah E.
Ngantcha, Marcus E.
de Vlam, Kurt
[J]. DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2297 - 2297
[7] The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004 (vol 60, pg 218, 2009)
Mease, P. J.
Reich, K.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (03) : 507 - 507
[8] Oral SDZ ASM 981: safety, pharmacokinetics and efficacy in patients with moderate to severe chronic plaque psoriasis (vol 143, pg 61, 2000)
Rappersberger, K
Komar, M
Ebelin, ME
Scott, G
Bueche, M
Burtin, P
Wolff, K
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) : 1130 - 1130
[9] RETRACTION: Serum calprotectin correlates with risk and disease severity in psoriasis patients and the decrease of calprotectin predicts better response to tumor necrosis factor inhibitors (Retraction of Vol 22, Pg 4299, 2018)
Qian, M.
Song, N. -J.
[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (10) : 3642 - 3642
[10] Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab (vol 28, pg 492, 2017)
Elewski, B.
Puig, L.
Mordin, M.
Gilloteau, I
Sherif, B.
Fox, T.
Gnanasakthy, A.
Papavassilis, C.
Strober, B.
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (06) : 571 - 571

← 1 2 →